S Shah, RL Venkatesan, A Gupta, MK Sanghavi… - BMC nephrology, 2019 - Springer
Background Reproductive function in women with end stage renal disease generally improves after kidney transplant. However, pregnancy remains challenging due to the risk of …
Background Chronic kidney disease (CKD) is estimated to affect 3% of pregnant women in high-income countries,(Piccoli et al., 2018,# 13860) which equates to between 15,000 …
P Webster, L Lightstone, DB McKay, MA Josephson - Kidney international, 2017 - Elsevier
Chronic kidney disease (CKD) affects up to 6% of women of childbearing age in high income countries, and is estimated to affect 3% of pregnant women. Advanced renal …
K Schutte-Nutgen, G Tholking… - Current drug …, 2018 - ingentaconnect.com
Background: The calcineurin inhibitor tacrolimus (Tac) is an integral part of the standard immunosuppressive regimen after renal transplantation (RTx). However, clinical …
K Schreiber, M Frishman, MD Russell, M Dey… - …, 2023 - academic.oup.com
Background The rationale behind this update on the 2016 British Society for Rheumatology (BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …
L Johannesson, S Järvholm - International journal of women's …, 2016 - Taylor & Francis
Even if reproductive medicine has been remarkably successful during the past few decades, with the introduction of in vitro fertilization in the late 1970s and intracytoplasmic sperm …
H Boulay, S Mazaud-Guittot, J Supervielle… - Clinical Kidney …, 2021 - academic.oup.com
Although pregnancy remains exceptional in women after heart, liver or lung transplant, obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant …
Uterine transplantation (UTx) is a fertility restoring treatment for women with absolute uterine factor infertility. At a time when there is no question of the procedure's feasibility, and as the …
P Coppola, E Kerwash, J Nooney, A Omran… - Frontiers in …, 2022 - frontiersin.org
Pregnancy-related physiological changes can alter the absorption, distribution, metabolism and excretion of medicines which may affect the safety and efficacy of the medicines …